Luciano Severgnini
Triesen, Liechtenstein
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies.
Journal: Annals of hematology
Published: November 20, 2023
Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients.
Journal: Journal of cancer research and clinical oncology
Published: November 10, 2022
Correlation between the level of evidence and the class of recommendations concerning the pharmacological aspects of the Guidelines of the European Society of Cardiology.
Journal: International journal of cardiology
Published: October 13, 2022
Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients.
Journal: Frontiers in oncology
Published: September 16, 2022
SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort study.
Journal: BMJ open
Published: May 25, 2022
Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response.
Journal: British journal of haematology
Published: October 23, 2021
SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria : Findings of a multicentric nationwide study.
Journal: Wiener klinische Wochenschrift
Published: September 09, 2021
Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients.
Journal: British journal of haematology
Published: June 07, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026